Skip to content
Screener

ANI Pharmaceuticals ANIP Price / earnings

Price / earnings at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
35.1×-720×
Viatris logo
ViatrisVTRS
6.5×-6.4×
ALN
Alnylam PharmaceuticalsALNY
54.8×—
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
105.5×—
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
6.9×-11.0×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
14.5×-175×

Other financials

Income statement

See full
Revenue$266.0M+25.9%
Gross profit$165.9M+21.3%
Operating income$40.5M+191%
Net income$24.7M+189%
EPS (diluted)$1.05+192%

Balance sheet

See full
Cash & equivalents$360.2M+65.4%
Total debt$301.5M-4.2%
Total equity$597.2M+36.7%
Total assets$1.5B+11.3%

Cash flow

See full
Operating cash flow$56.7M-25.3%
CapEx$3.1M-23.9%
Free cash flow$53.6M-25.3%

Valuation

See full
Market cap$1.88B+25.6%
Enterprise value$1.82B+14.3%
P/S1.9×-0.1×

Profitability

See full
Gross margin60.4%-0.7pp
Operating margin15.4%—
Net margin11.1%+10.0pp
FCF margin17.7%+0.9pp

Returns & leverage

See full
Return on equity21%+19.1pp
Debt / equity0.5×-0.2×
Current ratio2.9×+0.4×

Where this comes from

Calculated from ANI Pharmaceuticals’s reported figures.

market cap/net income=17.4×

Based on the most recent quarter.

The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 7:01 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001023024-26-000069

FAQ

What is ANI Pharmaceuticals's price / earnings?
ANI Pharmaceuticals (ANIP) reported price / earnings of 17.4× in Q2 2026.
What does price / earnings mean?
Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ask your AI about ANI Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude